Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? (Q40474186)

20 September 2017

Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? (English)

1 reference

20 September 2017

Honar Cherif

1

1 reference

PubMed ID

16856930

20 September 2017

Mats Kalin

series ordinal

2

1 reference

PubMed ID

16856930

20 September 2017

Magnus Björkholm

series ordinal

3

1 reference

20 September 2017

19 July 2006

1 reference

European Journal of Haematology

20 September 2017

1 reference

20 September 2017

77

1 reference

20 September 2017

4

1 reference

20 September 2017

288-292

1 reference

The epidemiology of sepsis in the United States from 1979 through 2000

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

Low incidence of candidaemia among neutropenic patients treated for haematological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00712.X

10.1111/J.1600-0609.2006.00712.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

16856930